Samira M Garonzik (Samira J Merali, Samira Garonzik, Samira Merali, Merali Samira)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 22

Top Topics

Randomized Controlled Trial

Hypertrophic Cardiomyopathy

Coronary Artery

Top Venues

American journal of cardiovascular drugs : drugs, devices, and other interventions

Arteriosclerosis, thrombosis, and vascular biology

CPT: pharmacometrics & systems pharmacology

Clinical and translational science

This page only lists publications with an associated author ORCID identifier.

Publications

Samira M Garonzik, Manting Chiang, Caroline Sychterz, Longfei Chao, Tara Simmons, Yiru Xu, Alice Zhao, Massimo Attanasio, Bindu Murthy, Vidya Perera
Effect of Activated Charcoal on Mavacamten Pharmacokinetics in Healthy Participants. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (4) (2024)
Samira M Garonzik, Manting Chiang, Caroline Sychterz, Longfei Chao, Tara Simmons, Yiru Xu, Alice Zhao, Massimo Attanasio, Bindu Murthy, Vidya Perera
Effect of Activated Charcoal on Mavacamten Pharmacokinetics in Healthy Participants. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (4) (2024)
Jennifer Nash, Mohammed Nooruddin Meah, Beth Whittington, Samuel Debono, Jennifer Raftis, Mark R Miller, Andrew Sorbie, Nicholas L Mills, Josselin Nespoux, Lorraine Bruce, Rodger Duffin, Neeraj Dhaun, Mairi Brittan, Longfei Chao, Samira M Garonzik, Minji Kim, Zhaoqing Wang, Yue Zhang, Shiqiang Jin, Beqing Wang, Marc Kozinn, David E Newby
PAR4 Antagonism in Patients With Coronary Artery Disease Receiving Antiplatelet Therapies. Arteriosclerosis, thrombosis, and vascular biology 44 (4) (2024)
Jennifer Nash, Mohammed Nooruddin Meah, Beth Whittington, Samuel Debono, Jennifer Raftis, Mark R Miller, Andrew Sorbie, Nicholas L Mills, Josselin Nespoux, Lorraine Bruce, Rodger Duffin, Neeraj Dhaun, Mairi Brittan, Longfei Chao, Samira M Garonzik, Minji Kim, Zhaoqing Wang, Yue Zhang, Shiqiang Jin, Beqing Wang, Marc Kozinn, David E Newby
PAR4 Antagonism in Patients With Coronary Artery Disease Receiving Antiplatelet Therapies. Arteriosclerosis, thrombosis, and vascular biology (2024)
Samira M Garonzik, Manting Chiang, Caroline Sychterz, Longfei Chao, Tara Simmons, Yiru Xu, Alice Zhao, Massimo Attanasio, Bindu Murthy, Vidya Perera
Effect of Activated Charcoal on Mavacamten Pharmacokinetics in Healthy Participants. American journal of cardiovascular drugs : drugs, devices, and other interventions (2024)
Anjali Tiku Owens, Milind Y Desai, Matthew T Wheeler, Anna Rodonski, Samira M Garonzik, Amy J Sehnert, Sara Saberi
Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Rationale for Clinically Guided Dose Titration to Optimize Individual Response. Journal of the American Heart Association 13 (17) (2024)
Jennifer Nash, Mohammed Nooruddin Meah, Beth Whittington, Samuel Debono, Jennifer Raftis, Mark R Miller, Andrew Sorbie, Nicholas L Mills, Josselin Nespoux, Lorraine Bruce, Rodger Duffin, Neeraj Dhaun, Mairi Brittan, Longfei Chao, Samira M Garonzik, Minji Kim, Zhaoqing Wang, Yue Zhang, Shiqiang Jin, Beqing Wang, Marc Kozinn, David E Newby
PAR4 Antagonism in Patients With Coronary Artery Disease Receiving Antiplatelet Therapies. Arteriosclerosis, thrombosis, and vascular biology (2024)
Xiaojie Wu, Nanye Chen, Peiwen Hsu, Jing Sun, Wenting Li, Qi Wang, Samira M Garonzik, Qiong Wei, Jicheng Yu, Guoying Cao, Haijing Yang, Lili Wang, Jingjing Wang, Yi Jin, Wei Liu, Jufang Wu, Jinjie He, Cheng Lyu, Wanzhen Li
Pharmacokinetics and safety of mavacamten in healthy Chinese participants with different CYP2C19 phenotypes. Clinical and translational science 17 (7) (2024)
Samira M Garonzik, Manting Chiang, Caroline Sychterz, Longfei Chao, Tara Simmons, Yiru Xu, Alice Zhao, Massimo Attanasio, Bindu Murthy, Vidya Perera
Effect of Activated Charcoal on Mavacamten Pharmacokinetics in Healthy Participants. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (4) (2024)
Anjali Tiku Owens, Milind Y Desai, Matthew T Wheeler, Anna Rodonski, Samira M Garonzik, Amy J Sehnert, Sara Saberi
Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Rationale for Clinically Guided Dose Titration to Optimize Individual Response. Journal of the American Heart Association (2024)
Sharif I Soleman, Juan Maya, Paul Levesque, Atif Mohammad, Lisa Christopher, Justin Schumacher, Aparna Nanduri, Pitchumani Sivakumar, Marc Kozinn, Philippe Costet, Chang Wang, Jeremy M Richter, Dara Hawthorne, Anh Bui, Veena S Rao, Daniel Dickerson, Jeffrey Testani, Francisco Ramírez-Valle, Frédéric Baribaud, Bindu Murthy, Samira M Garonzik
First-in-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-986308: A Renal Outer Medullary Potassium Channel Inhibitor. Clinical pharmacology and therapeutics (2024)
Samira M Garonzik, David H Salinger, Maria Palmisano, Amy J Sehnert, Neelima Thanneer, Hyunmoon Back, Julie D Seroogy, Daniel D Gretler, Amit Roy, Vidya Perera
Recommendation of mavacamten posology by model-based analyses in adults with obstructive hypertrophic cardiomyopathy. CPT: pharmacometrics & systems pharmacology (2024)
Xiaojie Wu, Nanye Chen, Peiwen Hsu, Jing Sun, Wenting Li, Qi Wang, Samira M Garonzik, Qiong Wei, Jicheng Yu, Guoying Cao, Haijing Yang, Lili Wang, Jingjing Wang, Yi Jin, Wei Liu, Jufang Wu, Jinjie He, Cheng Lyu, Wanzhen Li
Pharmacokinetics and safety of mavacamten in healthy Chinese participants with different CYP2C19 phenotypes. Clinical and translational science 17 (7) (2024)
Jennifer Nash, Mohammed Nooruddin Meah, Beth Whittington, Samuel Debono, Jennifer Raftis, Mark R Miller, Andrew Sorbie, Nicholas L Mills, Josselin Nespoux, Lorraine Bruce, Rodger Duffin, Neeraj Dhaun, Mairi Brittan, Longfei Chao, Samira M Garonzik, Minji Kim, Zhaoqing Wang, Yue Zhang, Shiqiang Jin, Beqing Wang, Marc Kozinn, David E Newby
PAR4 Antagonism in Patients With Coronary Artery Disease Receiving Antiplatelet Therapies. Arteriosclerosis, thrombosis, and vascular biology 44 (4) (2024)
Peter Chang, Vidya Perera, David H Salinger, Samira M Garonzik, Neelima Thanneer, Hyunmoon Back, Julie D Seroogy, Daniel D Gretler, Amy J Sehnert, Maria Palmisano, Amit Roy
Characterization of mavacamten pharmacokinetics in patients with hypertrophic cardiomyopathy to inform dose titration. CPT: pharmacometrics & systems pharmacology (2024)
Xiaojie Wu, Nanye Chen, Peiwen Hsu, Jing Sun, Wenting Li, Qi Wang, Samira M Garonzik, Qiong Wei, Jicheng Yu, Guoying Cao, Haijing Yang, Lili Wang, Jingjing Wang, Yi Jin, Wei Liu, Jufang Wu, Jinjie He, Cheng Lyu, Wanzhen Li
Pharmacokinetics and safety of mavacamten in healthy Chinese participants with different CYP2C19 phenotypes. Clinical and translational science 17 (7) (2024)
Samira M Garonzik, Wonkyung Byon, Yogesh T Patel, Amira Elsrougy, David Marchisin, Vidya Perera, Weidong Chen, Bing He, Bindu Murthy
Evaluation of safety, pharmacokinetics, and pharmacodynamics of apixaban in pediatric subjects at risk of venous or arterial thrombotic disorder. CPT: pharmacometrics & systems pharmacology (2023)
Samira M Garonzik, Zhaoqing Wang, Charles Frost, Stephanie Meadows-Shropshire, Dara Hawthorne, Jing Yang, Dietmar Seiffert
First-in-human study to assess the safety, pharmacokinetics, and pharmacodynamics of BMS-986141, a novel, reversible, small-molecule, PAR4 agonist in non-Japanese and Japanese healthy participants. Platelets 34 (1) (2023)
Michael J Jamieson, Wonkyung Byon, Richard W Dettloff, Matthew Crawford, Peter S Gargalovic, Samira M Garonzik, Joelle Onorato, Andres J Quintero, Cristina Russ
Apixaban Use in Obese Patients: A Review of the Pharmacokinetic, Interventional, and Observational Study Data. American journal of cardiovascular drugs : drugs, devices, and other interventions 22 (6) (2022)
Samira M Garonzik, Zhaoqing Wang, Charles Frost, Mario Callejo, Michael Hedrick, Lester Hui, Stephanie Meadows Shropshire, Ke Xu, Michel Bouvier, Mary M DeSouza, Jing Yang
New oral protease-activated receptor 4 antagonist BMS-986120: tolerability, pharmacokinetics, pharmacodynamics, and gene variant effects in humans. Platelets 33 (7) (2022)
Charles E Frost, Van Ly, Samira M Garonzik
Apixaban Pharmacokinetics and Pharmacodynamics in Subjects with Mild or Moderate Hepatic Impairment. Drugs in R&D 21 (4) (2021)
Samira M Garonzik, Wonkyung Byon, Elsa Myers, Xiodong Li, David Marchisin, Bindu Murthy
The Effects of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Volunteers: A Single-Sequence Crossover Study. American journal of cardiovascular drugs : drugs, devices, and other interventions 19 (6) (2020)